National Institute of Cancerología
39
6
6
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.7%
3 terminated/withdrawn out of 39 trials
81.3%
-5.3% vs industry average
18%
7 trials in Phase 3/4
8%
1 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (39)
Cervical Boost by Ablative Stereotactic Radiotherapy (SABR) vs Brachytherapy in Patients With Cervical Carcinoma
Role: lead
Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.
Role: lead
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Role: lead
Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients
Role: lead
Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease
Role: lead
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer
Role: lead
Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
Role: lead
Curcumin Supplementation in Cervical Cancer
Role: lead
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis
Role: lead
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer
Role: lead
A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT
Role: lead
Validation of the Genetic Signature 354849 as a Prognostic Method
Role: lead
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer
Role: lead
Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy
Role: lead
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
Role: lead
Effect of a Low Residue Diet in Comparison to the Dietetic Recommendations From the INCan in Cervical Cancer Patients
Role: lead
Clinical and Pathological Characteristics as Prognostic Factors in Locally Advanced Cervical Cancer
Role: lead
Factors Associated With Residual Disease In The Central Cone
Role: lead
microRNA Profile in Early-stage Cervical Cancer
Role: lead
Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial
Role: lead